Non-Hodgkin Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (B-cell Lymphoma, and T-cell Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026

Table of Content:

1. Introduction
   1. Research Scope
   2. Market Segmentation
   3. Research Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities
4. Key Insights
   1. Prevalence of Lymphoma - by Key Countries - 2018
   2. Pipeline Analysis
   3. Key Industry Developments
   4. Regulatory Scenario, by Key Regions
   5. Analysis of Economic Burden of Non-Hodgkin Lymphoma
   6. New Product Launches
   7. Overview of Emerging Treatments for Non-Hodgkin Lymphoma
5. Global Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
   1. Key Findings / Summary
   2. Market Analysis, Insights and Forecast – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Others
   3. Market Analysis, Insights and Forecast – By Disease Type
      1. B-cell Lymphoma
      2. T-cell Lymphoma
   4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
   5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
6. North America Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
   1. Key Findings / Summary
   2. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Others
   3. Market Analysis – By Disease Type
      1. B-cell Lymphoma
      2. T-cell Lymphoma
   4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
   5. Market Analysis – By Country
      1. U.S.
      2. Canada
7. Europe Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
   1. Key Findings / Summary
   2. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Others
   3. Market Analysis – By Disease Type
      1. B-cell Lymphoma
      2. T-cell Lymphoma
   4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
   5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
8. Asia Pacific Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
   1. Key Findings / Summary
   2. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Others
   3. Market Analysis – By Disease Type
      1. B-cell Lymphoma
      2. T-cell Lymphoma
   4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
   5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
9. Latin America Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
   1. Key Findings / Summary
   2. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Others
   3. Market Analysis – By Disease Type
      1. B-cell Lymphoma
      2. T-cell Lymphoma
   4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
   5. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
10. Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapy
       1. Immunotherapy
       2. Targeted Therapy
       3. Chemotherapy
       4. Others
    3. Market Analysis – By Disease Type
       1. B-cell Lymphoma
       2. T-cell Lymphoma
    4. Market Analysis – By Distribution Channel
       1. Hospital Pharmacies
       2. Retail Pharmacies & Drug Stores
       3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
       1. GCC Countries
       2. South Africa
       3. Rest of Middle East & Africa
11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
       1. Takeda Pharmaceutical Company Limited
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       2. AstraZeneca
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       3. Bayer AG
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       4. Novartis AG
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       5. Spectrum Pharmaceuticals, Inc.
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       6. Bristol Myers Squibb Company
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       7. Janssen Pharmaceuticals, Inc.
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       8. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       9. Merck & Co., Inc.
          1. Overview,
          2. Products & services,
          3. SWOT analysis,
          4. Recent developments,
          5. strategies,
          6. financials (based on availability)
       10. Spectrum Pharmaceuticals, Inc.
           1. Overview,
           2. Products & services,
           3. SWOT analysis,
           4. Recent developments,
           5. strategies,
           6. financials (based on availability)
       11. Other Prominent Players
           1. Overview,
           2. Products & services,
           3. SWOT analysis,
           4. Recent developments,
           5. strategies,
           6. financials (based on availability)
12. Strategic Recommendations

List of Figures:

Figure 1:  Global Non-Hodgkin Lymphoma Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Therapy, 2018 & 2026

Figure 3:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Immunotherapy, 2015-2026

Figure 4:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Targeted Therapy, 2015-2026

Figure 5:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Chemotherapy, 2015-2026

Figure 6:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 7:  Global Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Disease Type, 2018 & 2026

Figure 8:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by B-cell Lymphoma, 2015-2026

Figure 9:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by T-cell Lymphoma, 2015-2026

Figure 10:  Global Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 11:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 12:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Retail Pharmacies & Drug Stores, 2015-2026

Figure 13:  Global Non-Hodgkin Lymphoma Treatment Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 14:  Global Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 15:  North America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Therapy, 2018 & 2026

Figure 16:  North America Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Therapy, 2018

Figure 17:  North America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 18:  North America Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Disease Type, 2018

Figure 19:  North America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 20:  North America Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 21:  North America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 22:  North America Non-Hodgkin Lymphoma Treatment Market Value Share (%), By Country, 2018

Figure 23:  Europe Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Therapy, 2018 & 2026

Figure 24:  Europe Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Therapy, 2018

Figure 25:  Europe Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 26:  Europe Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Disease Type, 2018

Figure 27:  Europe Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 28:  Europe Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 29:  Europe Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Europe Non-Hodgkin Lymphoma Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Therapy, 2018 & 2026

Figure 32:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Therapy, 2018

Figure 33:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 34:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Disease Type, 2018

Figure 35:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 36:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 37:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 38:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 39:  Latin America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Therapy, 2018 & 2026

Figure 40:  Latin America Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Therapy, 2018

Figure 41:  Latin America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 42:  Latin America Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Disease Type, 2018

Figure 43:  Latin America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 44:  Latin America Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 45:  Latin America Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 46:  Latin America Non-Hodgkin Lymphoma Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 47:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Therapy, 2018 & 2026

Figure 48:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Therapy, 2018

Figure 49:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 50:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Disease Type, 2018

Figure 51:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 52:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 53:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 54:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 55:  Global Non-Hodgkin Lymphoma Treatment Market Share (%), By Company, 2018

List of Tables:

Table 1:  Global Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Therapy, 2015–2026

Table 2:  Global Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015–2026

Table 3:  Global Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Therapy, 2015-2026

Table 6:  North America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 7:  North America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Therapy, 2015-2026

Table 10:  Europe Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 11:  Europe Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Therapy, 2015-2026

Table 14:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 15:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Therapy, 2015-2026

Table 18:  Latin America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 19:  Latin America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Therapy, 2015-2026

Table 22:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 23:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026